Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BridgeBio Pharma (BBIO) Income from Non-Controlling Interests: 2019-2025

Historic Income from Non-Controlling Interests for BridgeBio Pharma (BBIO) over the last 7 years, with Sep 2025 value amounting to -$2.2 million.

  • BridgeBio Pharma's Income from Non-Controlling Interests rose 0.90% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.6 million, marking a year-over-year decrease of 15.46%. This contributed to the annual value of -$7.6 million for FY2024, which is 24.52% up from last year.
  • Latest data reveals that BridgeBio Pharma reported Income from Non-Controlling Interests of -$2.2 million as of Q3 2025, which was down 18.27% from -$1.9 million recorded in Q2 2025.
  • In the past 5 years, BridgeBio Pharma's Income from Non-Controlling Interests ranged from a high of $7.3 million in Q2 2022 and a low of -$8.0 million during Q1 2021.
  • In the last 3 years, BridgeBio Pharma's Income from Non-Controlling Interests had a median value of -$2.2 million in 2025 and averaged -$2.2 million.
  • As far as peak fluctuations go, BridgeBio Pharma's Income from Non-Controlling Interests surged by 227.44% in 2022, and later plummeted by 138.43% in 2023.
  • BridgeBio Pharma's Income from Non-Controlling Interests (Quarterly) stood at -$5.1 million in 2021, then skyrocketed by 41.65% to -$3.0 million in 2022, then grew by 26.82% to -$2.2 million in 2023, then declined by 7.29% to -$2.3 million in 2024, then grew by 0.90% to -$2.2 million in 2025.
  • Its Income from Non-Controlling Interests stands at -$2.2 million for Q3 2025, versus -$1.9 million for Q2 2025 and -$2.2 million for Q1 2025.